 | | | | | | |
 | 2014 |
| |
 | 2015 |
| |
 | 2016 |
| |
 | 2017 |
| |
  | 01 |
| |
  | 02 |
| |
  | 03 |
| |
  | 04 |
| |
  | 05 |
| |
  | 06 |
| |
  | 07 |
| |
  | 08 |
| |
  | 09 |
| |
  | 10 |
| |
  | 11 |
| |
| | 11/30/2017 | 02:00 PM | | Merck KGaA, Darmstadt, Germany, Opens Production Facility for Liquid Crystal Window Modules | |  |
| | 11/28/2017 | 02:00 PM | | Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients with Pre-Treated Advanced Gastric Cancer | |  |
| | 11/17/2017 | 02:01 PM | | Merck KGaA, Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Place to Work' by The Boston Globe | |  |
| | 11/13/2017 | 02:00 PM | | MilliporeSigma Introduces Stericup® Quick Release System for Improved Cell Culture Filtration | |  |
| | 11/09/2017 | 07:00 AM | | Merck KGaA, Darmstadt, Germany, Confirms Outlook for 2017 Despite a Challenging Third Quarter | |  |
| | 11/09/2017 | 12:00 PM | | NICE Recommends Cladribine Tablets for Highly Active Multiple Sclerosis | |  |
| | 11/05/2017 | 12:30 AM | | Merck KGaA, Darmstadt, Germany Presents Late Breaking Clinical Data from Phase II Trial of Sprifermin for Osteoarthritis Disease Modification | |  |
| | 11/01/2017 | 07:00 AM | | MilliporeSigma and Samsung BioLogics to Extend Strategic Alliance | |  |
  | 12 |
| |
 | 2018 |
| |